2020
DOI: 10.1016/j.ymgme.2019.11.421
|View full text |Cite
|
Sign up to set email alerts
|

Intracerebroventricular cerliponase alfa for CLN2 disease: Clinical practice considerations from US clinics

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles